SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
漂亮的天抒
Lv2
180 积分
2024-03-05 加入
最近求助
最近应助
互助留言
Adverse events of nivolumab plus ipilimumab versus nivolumab plus cabozantinib: a real-world pharmacovigilance study
7天前
已完结
Analysis of the adverse events of Aristada:A real-world study based on FAERS database
12天前
已完结
Linzagolix provides rapid, significant reduction of heavy menstrual bleeding in women with uterine fibroids
1个月前
已完结
EFFICACY AND SAFETY OF LINZAGOLIX (LGX) FOR THE TREATMENT OF HEAVY MENSTRUAL BLEEDING (HMB) DUE TO UTERINE FIBROIDS (UF): RESULTS FROM TWO PHASE 3 RANDOMIZED CLINICAL TRIALS
1个月前
已完结
Relugolix Combination Therapy Reduced Uterine Fibroid-Associated Pain in Two Phase 3 LIBERTY Studies [32B]
1个月前
已完结
Elagolix Treatment in Women with Heavy Menstrual Bleeding Associated with Uterine Fibroids: Efficacy and Safety Results From a Phase 2B Study
1个月前
已完结
LIBERTY: LONG-TERM EXTENSION STUDY DEMONSTRATING ONE-YEAR EFFICACY AND SAFETY OF RELUGOLIX COMBINATION THERAPY IN WOMEN WITH SYMPTOMATIC UTERINE FIBROIDS
1个月前
已完结
Up to 12 Months of Elagolix Sustained Menstrual Blood Loss Reduction in Women With Uterine Fibroids [OP04-5D]
1个月前
已完结
Up to 12 Months of Efficacy and Safety of Elagolix Treatment in Women with Heavy Menstrual Bleeding Associated with Uterine Fibroids
1个月前
已完结
Relugolix Combination Therapy for Uterine Fibroids
1个月前
已完结
没有进行任何应助
帮大忙了,么么哒
12天前
帮大忙了
1个月前
帮大忙了
1个月前
么么哒
1个月前
感谢
1个月前
点赞,感谢
1个月前
速度真快
1个月前
感谢
1个月前
感谢
1个月前
感谢
1个月前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论